MedPath

Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells

Phase 1
Completed
Conditions
The Sequelae Caused by Severe Brain Injury
Interventions
Biological: autologous adipose-derived mesenchymal stem cells
Registration Number
NCT01649700
Lead Sponsor
National Yang Ming Chiao Tung University
Brief Summary

The study is to investigate the efficacy and safety of autologous transplantation of adipose-derived mesenchymal stem cells in patients with the sequelae caused by severe brain injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Subject has a confirmed diagnosis of a brain AVM (arteriovenous malformation).
  • Stroke-like symptoms, including paralysis, caused by brain AVM hemorrhage.
  • Subject's modified Rankin scale (mRS) grades IV~V.
  • Ages between 20~40 years.
  • Estimated life expectancy must be greater than 2 months.
  • Signed informed consent from the subject.
Exclusion Criteria
  • Pregnancy test positive.
  • Subject infected with hepatitis C, HIV or syphilis.
  • Subject not suitable for liposuction surgery.
  • Subject not eligible for PET or MRI.
  • Subject enrolled in any other cell therapy studies within the past 30 days.
  • Subject deemed to be not suitable for the study by the investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mesenchymal stem cells treatmentautologous adipose-derived mesenchymal stem cellsAll subjects will receive autologous adipose-derived mesenchymal stem cells
Primary Outcome Measures
NameTimeMethod
Safety evaluation16 months

Safety evaluate through vital signs, the results of clinical lab tests and adverse events (AEs).

Secondary Outcome Measures
NameTimeMethod
Positron emission tomography13 months

18F-FDG used for the assessment of glucose metabolism in the brain

Magnetic Resonance Imaging16 months

changes in the volume of brain lesions

Electroencephalogram16 months

improvement of continuous slow-waves and irritative features

Neuropsychological assessment16 months
Electrodiagnostic Testing16 months

improvement of subjects' sensory neurologic pathways

Assessment of language and swallowing functions16 months

changes in levels of severity: normal/slight/mild/moderate/severe

Measure of the severity of disability16 months
Assessment of brain motor control16 months

measurement of the electrical activities in the muscles during specific testing procedures

Assessment of spasticity and strength16 months

Trial Locations

Locations (1)

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath